Antigen and immunostimulatory molecule surfaces

Antigen and immunostimulatory molecule surfaces refer to a functional concept in immunology and bioengineering rather than a single molecular target. These surfaces involve the strategic spatial arrangement of antigens and co-stimulatory ligands—such as CD80, CD86, or various Toll-like receptor (TLR) agonists—on a physical scaffold like a cell, virus-like particle, or synthetic nanoparticle (PubMed, 2020). By mimicking the natural presentation of signals by professional antigen-presenting cells (APCs), these surfaces facilitate the formation of an immunological synapse, leading to robust T-cell and B-cell activation (StatPearls, 2023). In therapeutic applications, such as cancer vaccines and adoptive cell therapies, these engineered surfaces are designed to overcome immune tolerance and enhance the magnitude and quality of the immune response against specific pathogens or malignant cells (NIH, 2022). However, because this term describes a broad category of functionalized interfaces rather than a specific protein or receptor, it is considered a descriptive classification for various immunotherapeutic platforms. The complexity of these surfaces requires precise control over ligand density and orientation to ensure efficacy while minimizing the risk of systemic toxicity or cytokine release syndrome (Nature Communications, 2019).

Other names

Antigen presentation surfacesImmunostimulatory surfacesSynthetic antigen-presenting cell surfacesFunctionalized nanoparticle surfacesMultivalent immune-activating interfaces

Mimicry of natural pathogen or antigen-presenting cell surfaces to provide multivalent display of antigens and co-stimulatory signals, thereby optimizing the activation and expansion of antigen-specific lymphocytes (Nature Reviews Immunology, 2021).